Gadopiclenol
Small Molecule
Overview
Gadopiclenol is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL4297634).
Patent & exclusivity (US)
Per the FDA Orange Book (7 approved US products), the latest listed US patent on Gadopiclenol expires 17 Jan 2040 and exclusivity 20 Feb 2029. Generic API sourcing typically opens up once these lapse.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.